AI for drug discovery, clinical trials, molecular design, and pharmacovigilance
12
Skills
5
Workflows
15
Categories
Identify promising drug targets by analyzing genomic data, protein structures, and disease pathways using AI-driven computational biology.
Optimize clinical trial design including endpoint selection, patient stratification, and site selection to improve success rates.
Design novel drug molecules with desired properties using generative chemistry models and ADMET prediction algorithms.
Monitor and detect adverse drug events from clinical data, patient reports, and medical literature for pharmacovigilance compliance.
Identify potential biomarkers from multi-omics data for disease diagnosis, treatment selection, and clinical trial enrichment.
Predict and analyze protein 3D structures to support drug design, binding site identification, and protein-protein interaction studies.
Assist with regulatory submission preparation including eCTD compilation, document formatting, and compliance checking against FDA/EMA guidelines.
Monitor pharmaceutical manufacturing quality with real-time process analytics, batch release testing, and deviation investigation support.
Accelerate clinical trial recruitment by identifying eligible patients from EHR data and optimizing recruitment campaigns.
Analyze real-world data from EHRs, claims databases, and registries to generate evidence supporting drug efficacy and safety.
Optimize pharmaceutical supply chains including cold chain logistics, demand forecasting, and regulatory compliance across markets.
Generate medical affairs content including medical communications, KOL presentations, and scientific literature summaries.
Accelerated drug discovery workflow using AI to identify drug targets, screen compound libraries, predict molecular properties, and optimize lead candidates for clinical development.
AI-powered clinical trial management workflow that optimizes protocol design, site selection, patient recruitment, and monitors trial progress for faster drug development.
Automated pharmacovigilance workflow that collects adverse event reports, performs signal detection, and generates regulatory safety reports for marketed drugs.
Generative AI workflow for molecular design that creates novel drug-like molecules with specified properties, accelerating the hit-to-lead optimization phase.
Automated regulatory affairs workflow that compiles, validates, and formats submission documents for FDA, EMA, and other regulatory authority drug approval filings.